The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target

Survival rate for Chondrosarcoma (CHS) is at a standstill, more effective treatments are urgently needed. Consequently, a better understanding of CHS biology and its immune environment is crucial to identify new prognostic factors and therapeutic targets. Here, we exhaustively describe the immune la...

Descripción completa

Detalles Bibliográficos
Autores principales: Iseulys, Richert, Anne, Gomez-Brouchet, Corinne, Bouvier, Gonzague, Du Bouexic De Pinieux, Marie, Karanian, Jean-Yves, Blay, Aurélie, Dutour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961717/
https://www.ncbi.nlm.nih.gov/pubmed/31956474
http://dx.doi.org/10.1016/j.jbo.2019.100271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961717/
https://www.ncbi.nlm.nih.gov/pubmed/31956474
http://dx.doi.org/10.1016/j.jbo.2019.100271

Ejemplares similares